Combination of ultrasound and fine needle biopsy can reliably identify malignant lymph nodes in women with breast cancer
The combination of ultrasound and find needle
biopsy can reliably identify malignant lymph nodes in women with
breast cancer, allowing some patients to avoid an additional surgical
procedure, according to a presentation at the annual meeting of
the Radiological Society of North America.
For some breast cancer patients, chemotherapy
may be necessary before surgery. For these women, it is important
to establish whether disease has spread to the lymph nodes before
chemotherapy begins. Rather than undergo a sentinel lymph node sampling
surgical procedure, doctors can use ultrasound-guided fine needle
aspiration to confirm lymph-node disease without surgery.
“The goal of the study was to use ultrasound
to preoperatively assess the axillary lymph nodes. If we can use
ultrasound to stage the axilla and identify metastatic disease,
we can save some women the additional surgery,” said Alexis Nees,
MD, study presenter.
In the current work, researchers used ultrasound
with 57 women newly diagnosed with breast cancer to identify the
axillary lymph nodes and determine if their appearance was normal
or abnormal. If they looked abnormal, a small 22-gauge needle was
inserted into the node to extract a specimen for pathological analysis.
The technique required only local anesthesia. Both sentinel lymph
node sampling and axillary node dissection are full surgical procedures.
Patients with positive nodes using the combination
technique then had breast surgery and either sentinel lymph node
sampling or axillary node dissection.
Pathology reports from surgery were compared with results from the
ultrasound-guided fine needle aspiration. Of the women whose ultrasound
showed abnormal lymph nodes, 92.8 percent had cancerous nodes at
surgery. Furthermore, all women with an abnormal ultrasound and
a positive biopsy were found to have cancer in their lymph nodes
at surgery.
“Both those numbers are extremely high,”
said Nees. “This tells us that axillary ultrasound combined with
ultrasound-guided fine needle aspiration of abnormal lymph nodes
can identify some patients with cancer in their lymph nodes. These
patients can proceed with chemotherapy or definitive surgery and
be spared an additional surgical procedure.”
Nees emphasized the technique is not reliable
to rule out spread of disease; it can only confirm positive lymph
nodes. Because of that, if the test comes back negative, sentinel
lymph node sampling is still necessary.
|